A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities

SM Mousavi, M Zarei, SA Hashemi… - Artificial cells …, 2019 - Taylor & Francis
Rhodanines are accepted as advantaged heterocycles in medicinal chemistry as one of the
4-thiazolidinones subtypes. The aim of this paper is to analyze the features of rhodanine and …

Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases

T Tomašić, L Peterlin Masic - Current topics in medicinal …, 2014 - ingentaconnect.com
The modulation of DNA topology by DNA gyrase and topoisomerase IV, both of which are
type IIA topoisomerases and found in most bacteria, is a function vital to DNA replication …

Structure-based discovery of substituted 4, 5′-bithiazoles as novel DNA gyrase inhibitors

M Brvar, A Perdih, M Renko, G Anderluh… - Journal of medicinal …, 2012 - ACS Publications
Bacterial DNA gyrase is a well-established and validated target for the development of novel
antibacterials. Starting from the available structural information about the binding of the …

Drug screening of rhodanine derivatives for antibacterial activity

S Maddila, S Gorle… - Expert Opinion on Drug …, 2020 - Taylor & Francis
Introduction: Bacteriological infections are a major risk to human health. These include all
hospital and public-acquired infections. In drug discovery, rhodanines are privileged …

[HTML][HTML] Rhodanine scaffold: A review of antidiabetic potential and structure–activity relationships (SAR)

AKD bin Ahmad Kamar, LJ Yin, CT Liang… - Medicine in Drug …, 2022 - Elsevier
Diabetes is a chronic medical condition due to the lack of insulin or ineffective use of insulin.
In recent years, diabetes has become one of the rapidly growing chronic diseases, and it …

Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents

GS Basarab, JI Manchester, S Bist… - Journal of medicinal …, 2013 - ACS Publications
The discovery and optimization of a new class of bacterial topoisomerase (DNA gyrase and
topoisomerase IV) inhibitors binding in the ATP domain are described. A fragment molecule …

Anti-tuberculosis Mur inhibitors: structural insights and the way ahead for development of novel agents

K Mehta, M Khambete, A Abhyankar, A Omri - Pharmaceuticals, 2023 - mdpi.com
Mur enzymes serve as critical molecular devices for the synthesis of UDP-MurNAc-
pentapeptide, the main building block of bacterial peptidoglycan polymer. These enzymes …

Dynophore-based approach in virtual screening: A case of human dna topoisomerase IIα

M Janežič, K Valjavec, KB Loboda, B Herlah… - International Journal of …, 2021 - mdpi.com
In this study, we utilized human DNA topoisomerase IIα as a model target to outline a
dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a …

Design, synthesis and biological evaluation of 4, 5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors

T Tomašič, M Mirt, M Barančoková, J Ilaš… - Bioorganic & medicinal …, 2017 - Elsevier
Abstract Development of novel DNA gyrase B inhibitors is an important field of antibacterial
drug discovery whose aim is to introduce a more effective representative of this mechanistic …

Antimicrobial activity of rhodanine-3-acetic acid derivatives

M Krátký, J Vinšová, J Stolaříková - Bioorganic & Medicinal Chemistry, 2017 - Elsevier
Abstract Twenty-four 2-(4-oxo-2-thioxothiazolidin-3-yl) acetic acid (rhodanine-3-acetic acid)-
based amides, esters and 5-arylalkylidene derivatives were synthesized, characterized and …